Pharmacodynamics 2 (ppt 8) Flashcards
1
Q
Synergism
A
- combined effect of 2 drugs is greater than the sum of their effects when given separately
2
Q
Additivity
A
A drug adds to the potency of the first drug
3
Q
Potentiation
A
One drug doesn’t cause a response on its own, but enhances the response of another drug
4
Q
Prodrugs must be metabolized by…
A
Liver
5
Q
Magnitude of pharmacological response is proportionally related to
A
Drug conc. @ receptor site
6
Q
5 types of receptors or signaling mech. for drug actions
A
- steroid
- tyrosine kinase
- JAK-STAT
- ion channel
- GPCR
7
Q
Ligand gated ion-channel
A
- 5 subunits: alpha, beta, gamma, delta
- ACh binding to extracellular a subunit site=open channel
8
Q
G-protein coupled receptor
A
- regulate effector proteins via mediation of transducers (g proteins)
- ligands: hormones, pheromones, neurotransmitters, autacoids, xenobiotics
9
Q
G proteins
A
- heterotrimeric molecules
- 3 subunits attached to inner surface: alpha, beta, gamma
- beta gamma comples
- 4 families: G-alphas, G-alphai/G-alpha0, G-alpha q, G-alpha 12/13
10
Q
Enzyme-linked effector systems
A
Second messengers
11
Q
Enzyme-linked effector system types
A
- adenylate cyclase: cAMP system
- Phospholipase C: IP3-DAG system
- Phospholipase A2: A A system
12
Q
Gs family
A
- alpha s subunit
- positive action on adenylate cyclase & calcium channels
- increase heart rate, stim. neuronal activity
- ex: adrenergic beta-R
13
Q
Gi/G0 family
A
- alpha subunit: i & 0
- negative effect on adenylate cyclase and Ca2+ channels
- positive effect on K+ channel
- smooth m. relaxant, depresses neuronal activity
- ex: muscarinic M2-R, Opioid
14
Q
Gq/11 family
A
- alpha subunits: q, 11, 14, 15, 16
- positive effect on Phospholipase C
- smooth m. contraction, Ca2+ flux
- ex: adrenergic alpha 1R, Histamine H1
15
Q
G12/13 family
A
- alpha subunits: 12 and 13
- positive effects on Rho family of GTPases, and Na+/H+ exchange
- cytoskeletal funct., smooth m. contraction
16
Q
Tyrosine kinase receptor (TKR) states
A
- C1 State: inactive
- C2 state: active
17
Q
C-1 state
A
- transmembrane receptors have large extracellular binding sites, intracellular tails, and enxyme
18
Q
C-2 state
A
- ligan binds to both receptors, dimer formed, tyrosine kinase portion activated, ATP phosphorylates tyrosines on tail of other polypeptide, downstream signaling
19
Q
Nuclear receptors
A
- may be located in cytosol and migrate to nucleus post-binding
- long-lasting effect
- Ex: glucocorticoid receptos
20
Q
Up-regulation of receptors
A
- body increases # of receptors
- seen when receptors continuously deprived of ligands or continued antagonist use
- state of supersensitization
- ex: rebound hypertension in K9s following withdrawal of beta-adrenoceptor blockers (atenolol)
21
Q
Down-regulation
A
- cell decreases # receptors or protein population
- diminishes drug effects (tissues continuously exposed to agonist-> over-activation)
- drug-receptor complex undergoes endocytosis then metabolized
- leads to desensitization or refractoriness
- ex: continuous exposure to insulin